Literature DB >> 15573087

IL-10 stimulatory effects on human NK cells explored by gene profile analysis.

S Mocellin1, M Panelli, E Wang, C R Rossi, P Pilati, D Nitti, M Lise, F M Marincola.   

Abstract

The molecular mechanisms underlying the increase of natural killer (NK) cell anticancer activity mediated by interleukin (IL)-10 have not been elucidated. The aim of this study was to identify potential molecular mediators of IL-10 stimulatory effects by exploring the NK cell gene display induced by this cytokine. Gene profile was determined by high-throughput cDNA microarray and quantitative real-time PCR. In vitro, NK cells resting or conditioned with IL-10 were tested for cytotoxicity, migration and proliferation. IL-10 enhanced mRNA levels of cell activation/cytotoxicity-related genes (eg secretogranin, TIA-1, HMG-1, interferon-inducible genes) not upregulated by IL-2. In line with these findings, IL-10 increased NK cell in vitro cytotoxicity against Daudi cells. Unlike IL-2, IL-10 did not show any significant effect on NK cell in vitro proliferation and migration. However, gene profile analysis showed that IL-10 increased the expression of cell migration-related genes (eg L-selectin, vascular endothelium growth factor receptor-1, plasminogen activator, tissue; formyl peptide receptor, lipoxin A4 receptor), which might support a stimulatory effect not evident with the in vitro functional assay. Overall, gene profiling allowed us to formulate new hypotheses regarding the molecular pathways underlying the stimulatory effects of IL-10 on NK cells, supporting further investigation aimed at defining its role in cancer immune rejection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15573087     DOI: 10.1038/sj.gene.6364135

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  26 in total

Review 1.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

2.  IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells.

Authors:  Ju Yeong Park; Suk Hyung Lee; Suk-Ran Yoon; Young-Jun Park; Haiyoung Jung; Tae-Don Kim; Inpyo Choi
Journal:  Mol Cells       Date:  2011-07-29       Impact factor: 5.034

Review 3.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.

Authors:  Andrzej Szkaradkiewicz; Tomasz M Karpiński; Michał Drews; Maciej Borejsza-Wysocki; Przemysław Majewski; Ewa Andrzejewska
Journal:  J Biomed Biotechnol       Date:  2010-04-27

Review 5.  Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation.

Authors:  Christine A Biron
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

6.  Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells.

Authors:  L R Grant; Z-J Yao; C M Hedrich; F Wang; A Moorthy; K Wilson; D Ranatunga; J H Bream
Journal:  Genes Immun       Date:  2008-04-10       Impact factor: 2.676

Review 7.  Global transcriptional analysis for biomarker discovery and validation in cellular therapies.

Authors:  David F Stroncek; Ping Jin; Ena Wang; Jiagiang Ren; Marianna Sabatino; Francesco M Marincola
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 8.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

9.  NKp46+ lamina propria natural killer cells undergo metabolic reprogramming in a mouse experimental colitis model.

Authors:  Hongjian Zhou; Xingwang Xie; Bin Jiang; Chao Ke
Journal:  Inflamm Res       Date:  2020-02-10       Impact factor: 4.575

Review 10.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.